Zantac Pulled Cancer Risk Cited

2020-04-02 13

The FDA has pulled Zantac and related generic drugs from store shelves citing a cancer risk.

Videos similaires

FDA Issues Recall Notice of Common Blood Pressure Medication Citing Cancer Risk

FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks

Tig-tatlong brands ng Tocilizumab at Baricitinib, inaprubahan na ng FDA; FDA, muling nagbabala vs nagbebenta ng pekeng COVID-19 medicines online

FDA Finds Contaminants In Heartburn Drugs

Cancer : le médicament Zantac le favorise

CVS suspends heartburn drug Zantac over cancer fears

OSHA News: Remington Arms Cited

Pilot error cited in Rio-Paris crash

[NewsLife] DOT's achievements cited [06|14|16]

Web Analytics